Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tropea

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Oncogene|May 18, 2000
A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblastsP Bossù, M Vanoni, V Wanke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 24, 2011
Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channelsKathryn Schierberl, Jin Hao, Thomas F Tropea, et al.
Clinical Chemistry|September 19, 2023
Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau PathologyJu Hee Kang, Magdalena Korecka, Edward B Lee, et al.
Molecular Psychiatry|February 15, 2017
Enhancing VTA Ca<sub>v</sub>1.3 L-type Ca<sup>2+</sup> channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbensA Martínez-Rivera, J Hao, T F Tropea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2017
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's diseaseThomas F Tropea, Sharon X Xie, Jacqueline Rick, et al.
Annals of Clinical and Translational Neurology|March 31, 2023
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body diseaseKatheryn A Q Cousins, David J Irwin, Alice Chen-Plotkin, et al.
Breast Cancer Research and Treatment|June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patientsC Nisticò, C Garufi, M Milella, et al.
Nature|April 1, 2021
Author Correction: A growth-factor-activated lysosomal K<sup>+</sup> channel regulates Parkinson's pathologyJinhong Wie, Zhenjiang Liu, Haikun Song, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2021
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseWhitley W Aamodt, Teresa Waligorska, Junchao Shen, et al.
Nature|January 28, 2021
A growth-factor-activated lysosomal K<sup>+</sup> channel regulates Parkinson's pathologyJinhong Wie, Zhenjiang Liu, Haikun Song, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Oncogene|May 18, 2000
A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblastsP Bossù, M Vanoni, V Wanke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 24, 2011
Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channelsKathryn Schierberl, Jin Hao, Thomas F Tropea, et al.
Clinical Chemistry|September 19, 2023
Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau PathologyJu Hee Kang, Magdalena Korecka, Edward B Lee, et al.
Molecular Psychiatry|February 15, 2017
Enhancing VTA Ca<sub>v</sub>1.3 L-type Ca<sup>2+</sup> channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbensA Martínez-Rivera, J Hao, T F Tropea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2017
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's diseaseThomas F Tropea, Sharon X Xie, Jacqueline Rick, et al.
Annals of Clinical and Translational Neurology|March 31, 2023
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body diseaseKatheryn A Q Cousins, David J Irwin, Alice Chen-Plotkin, et al.
Breast Cancer Research and Treatment|June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patientsC Nisticò, C Garufi, M Milella, et al.
Nature|April 1, 2021
Author Correction: A growth-factor-activated lysosomal K<sup>+</sup> channel regulates Parkinson's pathologyJinhong Wie, Zhenjiang Liu, Haikun Song, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2021
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseWhitley W Aamodt, Teresa Waligorska, Junchao Shen, et al.
Nature|January 28, 2021
A growth-factor-activated lysosomal K<sup>+</sup> channel regulates Parkinson's pathologyJinhong Wie, Zhenjiang Liu, Haikun Song, et al.
Pageof 12